GPx

About:

GPx is a digital therapeutics company that revolutionizes remote chronic disease management with bloodless blood tests.

Twitter/X: GPx_Boston

Top Investors: Elev X!, D4V, IDEO, NEC X, PharmStars

Description:

GPx is a biotech company that revolutionizes remote chronic disease management with bloodless blood tests. It is dedicated to transforming the standard of care of cardiorenal diseases and enabling patients to better understand their condition, much like the continuous glucose monitor has transformed diabetes care. The company was founded in 2020 and is based in Boston, Massachusetts.

Total Funding Amount:

$4.06M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2020-01-01

Contact Email:

contact(AT)generalprognostics.com

Founders:

Javier Echenique, Sean (Shunsuke) Matsuoka, Sidhant Jena

Number of Employees:

11-50

Last Funding Date:

2024-11-12

IPO Status:

Private

Industries: